According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

Scientists have long known that bacteriophages, viruses that infect bacteria, live in our gut, but exactly what they do has ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

Wayne Grube Jr., CEO of BC3 Technologies, joins Jenyne Donaldson to talk about the company's new SEAL Hemostatic Wound Spray ...

When it comes to protecting a harvest, Andy Fles believes soft pesticide treatments have a place in the vineyard.

Lepodisiran, a new drug, slashed levels of “stealthy cholesterol”—a hidden heart risk affecting 1 in 5 people—by up to 95% in early trials. Here's what you need to know about the condition and the ...

One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual surgery required. Today, the company announced early data from animals and ...

Drugs that target these checkpoints, known as checkpoint inhibitors, are now an important part of the treatment for many people with liver cancer, especially if the cancer can’t be removed with ...

Plans to spray for spongy moths in five Minnesota counties have been scrapped after the federal funding for the aerial treatments didn’t come through. The Minnesota Department of Agriculture ...